Taken together, evidence suggests that inositol phosphates have pharmacological effects on increased insulin sensitivity, improved insulin resistance and other metabolic profiles, as well as decreased obesity and adiposity. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.